Categories
-
Adhesives
6
Amines
98
Amino Acids
184
Analytical Reagents
701
Antibiotics
254
Bioactive Small Molecules
735
Aroma Chemicals
212
Biochemicals
1040
Boronic Acids
4
Buffers
97
Building Blocks
1901
Carbohydrates
179
Catalysts
108
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
261
Flavours and Fragrance Materials
212
Fluorinated Products
50
Furans
6
Gases in Solution
48
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
341
Ion-Pair Reagents
23
Ligands
80
Organics
1417
Oxazoles
3
Peptide Reagents
90
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
105
Research Organics & Inorganics
790
Salts
296
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
301
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
49
Water Analysis
12
Ibandronate sodium salt
(46946205 | 138926-19-9)
CAS: | 138926-19-9 |
---|---|
Molecular Formula: | C9H22NNaO7P2 |
Molecular Weight: | 341.21 |
Availablility: | Inquire for Status |
---|---|
Downloads: | | |
46946205-1g | 1g | £29.50 | |
46946205-5g | 5g | £83.50 | |
Bulk Order |
46946205-1g | 1g | €41.30 | |
46946205-5g | 5g | €116.90 | |
Bulk Order |
46946205-1g | 1g | $44.30 | |
46946205-5g | 5g | $125.30 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 46946205 | ||||
Product Name | Ibandronate sodium salt | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 138926-19-9 | ||||
Molecular Formula | C9H22NNaO7P2 | ||||
Molecular Weight | 341.21 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2931399090 |
Product Specification
Assay/Purity | 99% min | ||||
Heavy metals | <10ppm | ||||
Loss on Drying | <10% | ||||
Phosphate | <1% | ||||
Appearance | White Powder | ||||
Identification (IR) | Complies with reference standard | ||||
Phosphite | <1% |
Safety Information
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|